The Africa injectable drugs market has been growing significantly over the past decade. Injectable drugs are pharmaceutical drugs that are administered using a needle and syringe directly into the body. The advantages of injectable drugs include bypassing first-pass metabolism in the liver, providing quicker onset of action and being more predictable in terms of absorption into the body. They are widely used to deliver medications for anesthesia, immunotherapy, chemotherapy and other clinical conditions that require rapid absorption of the drug. Some common therapeutic applications of injectable drugs are pain management, cardiovascular disorders, internal infections and metabolic disorders.
The market for injectable drugs in Africa is estimated to be valued at US$ 326.53 Mn in 2024 and is expected to exhibit a CAGR of 4.7% over the forecast period 2024 to 2031.
The Africa Injectable Drugs Market Trends prevalence of chronic diseases, growing geriatric population, rising healthcare expenditure and improved healthcare infrastructure are the major factors driving the growth of the Africa injectable drugs market.
Key Takeaways
Key players operating in the Africa injectable drugs are Apotex Inc., Fresenius Kabi India Pvt. Ltd., Hikma Pharmaceuticals PLC, Pfizer Inc., Bristol-Myers Squibb Company, Gland Pharma Limited, hameln pharma gmbh, Merck Co., Inc., AbbVie Inc., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, and PANPHARMA S.A.
The demand for injectable drugs in Africa has been steadily rising over the past few years owing to the growing incidence of chronic diseases such as cancer, cardiovascular disorders and infections. According to WHO, chronic diseases accounted for over 60% of diseases in Africa in 2020.
Major pharmaceutical companies have been expanding their injectable drug portfolio and manufacturing capabilities in Africa through strategic collaborations and acquisitions. For instance, Pfizer opened a new state-of-the-art sterile injectable facility in Morocco in 2021 to boost supply in Africa and other emerging markets.
Get More Insights on- Africa Injectable Drugs Market